Disposition kinetics of cimetidine and ranitidine in endotoxin pretreated rats

Juzar S. Kaka, Musbah O M Tanira, Khalil I. Al-Khamls

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Clmetldlne and ranitidine are used In patients with lifethreathenlng gram-negative Infections, endotoxemla and acute stress erosions. Disposition kinetics of clmetldlne and ranitidine In endotoxin pretreated rats was Investigated. The H2 antagonists were administered intravenously 24 h after endotoxin (10 mg/kg) pretreatment. This endotoxin dosage resulted in 50% mortality in rats. Blood samples (0.25 ml) were collected at different timed intervals. No significant differences were observed in plasma clearance, half-life and volume of distribution between endotoxin pretreated and control rats. Clmetldlne is eliminated extensively by the renal route in animals and man with metabolism being a minor process. Ranitidine is metabolized to a large extent (70% in rats, while in humans this represents a minor process. No significant changes in clmetldlne and ranitidine disposition parameters in endotoxin pretreated rats were observed. These results suggest that clmetldlne and ranitidine may be used in normal dosages in endotoxemla patients since their pharmacokinetic parameters would not be affected under these circumstances.

Original languageEnglish
Pages (from-to)49-59
Number of pages11
JournalDrug and Chemical Toxicology
Volume12
Issue number1
DOIs
Publication statusPublished - 1989

Fingerprint

Ranitidine
Cimetidine
Endotoxins
Rats
Kinetics
Rat control
Pharmacokinetics
Metabolism
Erosion
Animals
Blood
Half-Life
Plasmas
Kidney
Mortality
Infection

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology
  • Health, Toxicology and Mutagenesis
  • Public Health, Environmental and Occupational Health
  • Chemical Health and Safety
  • Chemistry(all)

Cite this

Disposition kinetics of cimetidine and ranitidine in endotoxin pretreated rats. / Kaka, Juzar S.; Tanira, Musbah O M; Al-Khamls, Khalil I.

In: Drug and Chemical Toxicology, Vol. 12, No. 1, 1989, p. 49-59.

Research output: Contribution to journalArticle

@article{52ccd408f74a4755ab89dc5a36106ff9,
title = "Disposition kinetics of cimetidine and ranitidine in endotoxin pretreated rats",
abstract = "Clmetldlne and ranitidine are used In patients with lifethreathenlng gram-negative Infections, endotoxemla and acute stress erosions. Disposition kinetics of clmetldlne and ranitidine In endotoxin pretreated rats was Investigated. The H2 antagonists were administered intravenously 24 h after endotoxin (10 mg/kg) pretreatment. This endotoxin dosage resulted in 50{\%} mortality in rats. Blood samples (0.25 ml) were collected at different timed intervals. No significant differences were observed in plasma clearance, half-life and volume of distribution between endotoxin pretreated and control rats. Clmetldlne is eliminated extensively by the renal route in animals and man with metabolism being a minor process. Ranitidine is metabolized to a large extent (70{\%} in rats, while in humans this represents a minor process. No significant changes in clmetldlne and ranitidine disposition parameters in endotoxin pretreated rats were observed. These results suggest that clmetldlne and ranitidine may be used in normal dosages in endotoxemla patients since their pharmacokinetic parameters would not be affected under these circumstances.",
author = "Kaka, {Juzar S.} and Tanira, {Musbah O M} and Al-Khamls, {Khalil I.}",
year = "1989",
doi = "10.3109/01480548908999142",
language = "English",
volume = "12",
pages = "49--59",
journal = "Drug and Chemical Toxicology",
issn = "0148-0545",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Disposition kinetics of cimetidine and ranitidine in endotoxin pretreated rats

AU - Kaka, Juzar S.

AU - Tanira, Musbah O M

AU - Al-Khamls, Khalil I.

PY - 1989

Y1 - 1989

N2 - Clmetldlne and ranitidine are used In patients with lifethreathenlng gram-negative Infections, endotoxemla and acute stress erosions. Disposition kinetics of clmetldlne and ranitidine In endotoxin pretreated rats was Investigated. The H2 antagonists were administered intravenously 24 h after endotoxin (10 mg/kg) pretreatment. This endotoxin dosage resulted in 50% mortality in rats. Blood samples (0.25 ml) were collected at different timed intervals. No significant differences were observed in plasma clearance, half-life and volume of distribution between endotoxin pretreated and control rats. Clmetldlne is eliminated extensively by the renal route in animals and man with metabolism being a minor process. Ranitidine is metabolized to a large extent (70% in rats, while in humans this represents a minor process. No significant changes in clmetldlne and ranitidine disposition parameters in endotoxin pretreated rats were observed. These results suggest that clmetldlne and ranitidine may be used in normal dosages in endotoxemla patients since their pharmacokinetic parameters would not be affected under these circumstances.

AB - Clmetldlne and ranitidine are used In patients with lifethreathenlng gram-negative Infections, endotoxemla and acute stress erosions. Disposition kinetics of clmetldlne and ranitidine In endotoxin pretreated rats was Investigated. The H2 antagonists were administered intravenously 24 h after endotoxin (10 mg/kg) pretreatment. This endotoxin dosage resulted in 50% mortality in rats. Blood samples (0.25 ml) were collected at different timed intervals. No significant differences were observed in plasma clearance, half-life and volume of distribution between endotoxin pretreated and control rats. Clmetldlne is eliminated extensively by the renal route in animals and man with metabolism being a minor process. Ranitidine is metabolized to a large extent (70% in rats, while in humans this represents a minor process. No significant changes in clmetldlne and ranitidine disposition parameters in endotoxin pretreated rats were observed. These results suggest that clmetldlne and ranitidine may be used in normal dosages in endotoxemla patients since their pharmacokinetic parameters would not be affected under these circumstances.

UR - http://www.scopus.com/inward/record.url?scp=0024547133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024547133&partnerID=8YFLogxK

U2 - 10.3109/01480548908999142

DO - 10.3109/01480548908999142

M3 - Article

VL - 12

SP - 49

EP - 59

JO - Drug and Chemical Toxicology

JF - Drug and Chemical Toxicology

SN - 0148-0545

IS - 1

ER -